beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) Peptide
Quick Overview for beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) Peptide (ABIN936827)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- APWAPPQSPR RPELPDLAPE PRYAHIPVRI KEQVVGLLAW NNCSCESSGG
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of B4 GALNT1 antibody,
Alternative Names: B4GALNT1 control peptide, B4GALNT1 antibody Blocking Peptide, Anti-B4GALNT1 Blocking Peptide, Beta 14-N-Acetyl-Galactosaminyl Transferase 1 Blocking Peptide, GALGT Blocking Peptide, GALNACT Blocking Peptide, B4GAL, BGAL-4, BGAL 4, BGAL-4 Blocking Peptide, BGAL 4 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
-
Background
- GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. B4GALNT1(GalNAc-T) catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively.GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids.
-
Molecular Weight
- 59 kDa
Target
-